ClinicalTrials.Veeva

Menu

Evaluation of the Antibiofilmogramme Test During Orthopaedic Device-Related Infection (BJIBiofilm)

B

BioFilm Control

Status

Unknown

Conditions

Prosthetic Joint Infection
Biofilm
Staphylococcus Aureus

Treatments

Diagnostic Test: Antibiofilmogramme

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03263832
2015-A0022472

Details and patient eligibility

About

This is an observational study that does not change routine care.

The primary objective of this study is to investigate the correlation between the administration of an antibiotherapy able to prevent biofilm formation according to the results of the Antibiofilmogramme test, and the relapse of the infection for patient with orthopaedic device-related infection.

Full description

The secondary objectives are:

A. Investigate the role of antibiogram-antibiofilmogramme concordance (in terms of S. aureus strains and prescribed antibiotics) in orthopaedic device-related infection management.

B. Investigate the capacity of S. aureus isolates to form biofilm in presence/absence of antibiotics.

C. Create an S. aureus strain collection for future ancillary studies

Enrollment

45 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must have been informed and received a non-opposition consent form
  • Patient with a monomicrobial S. aureus bone and joint infections
  • Patient with prosthetic or orthopaedic device

Exclusion criteria

  • Bone and joint infection from pressure ulcer, vascular injury or diabetic foot ulcer
  • Polymicrobial prosthetic joint infection
  • The patient is participating in, or has participated in within the past 3 months, another interventional study, or is currently in an exclusion period determined by a preceding study
  • Patient is under judicial protection, under tutorship or curatorship
  • The patient expresses his opposition to participate to the study
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient or breastfeeding
  • Emergency situation precluding correct study implementation

Trial design

45 participants in 2 patient groups

Exposed
Description:
Patients with a monomicrobial S. aureus orhtopaedic device-related infection who have received antibiotherapy able to prevent biofilm formation following surgical intervention (from day 0 to day 7). Upon inclusion, antibiograms were performed on the S. aureus isolated as part of routine procedure. S. aureus isolates was further analysed via an Antibiofilmogramme, which is an experimental element added by this research.
Treatment:
Diagnostic Test: Antibiofilmogramme
Not Exposed
Description:
Patients with a monomicrobial S. aureus orhtopaedic device-related infection who not have received antibiotherapy able to prevent biofilm formation following surgical intervention (from day 0 to day 7). Upon inclusion, antibiograms were performed on the S. aureus isolated as part of routine procedure. S. aureus isolates was further analysed via an Antibiofilmogramme, which is an experimental element added by this research.
Treatment:
Diagnostic Test: Antibiofilmogramme

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems